AS-35: Five-Year Outcomes after Drug-Eluting Stent versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease

2010 ◽  
Vol 105 (9) ◽  
pp. 16A
Author(s):  
Duk-Woo Park ◽  
Jong-Young Lee ◽  
Won-Jang Kim ◽  
Soo-Jin Kang ◽  
Seung-Whan Lee ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Left Main Coronary Artery ◽  
Artery Bypass ◽  
Drug Eluting Stent ◽  
Bypass Grafting ◽  
Left Main ◽  
Main Coronary Artery Disease ◽  
Drug Eluting ◽  
Artery Disease

The Contemporary Management of Left Main Coronary Artery Disease

2021 ◽  
Vol 17 ◽  
Author(s):  
Jonathan A. Mailey ◽  
Mark S. Spence
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Left Main Coronary Artery ◽  
Artery Bypass ◽  
Current Evidence ◽  
Drug Eluting Stent ◽  
Left Main ◽  
Main Coronary Artery Disease ◽  
Current Evidence Base ◽  
Artery Disease

: The ‘gold standard’ in the management of left main coronary artery disease has historically been coronary artery bypass surgery. Recent innovations in drug-eluting stent technology coupled with the increasing utility of physiology and imaging guidance for procedures has led to an evolving role for percutaneous coronary intervention in left main disease of low and intermediate anatomical complexity. This revascularization modality carries the clear advantage of being less invasive and significantly reducing recovery times. This practice is currently supported by international guidelines. However, it remains a controversial topic in the field of interventional cardiology, and the longer-term outcomes from a percutaneous strategy have been questioned. This review describes the current evidence base for the assessment and choice of intervention in left main coronary artery disease. The percutaneous revascularization techniques and use of imaging to optimize procedures and improve clinical outcomes will be discussed.

Sign in / Sign up

Export Citation Format

Share Document